$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Glaucoma is a group of diseases characterized by optic neuropathy and retinopathy that ultimately leads to irreversible blindness1,2. It is estimated that by 2020 over 70 million people worldwide will be living with some form of the disease3,4,5,6,7. Primary open angle glaucoma (POAG), the most prevalent type of glaucoma, is characterized by a decrease in aqueous humor (AH) outflow leading to increased intraocular pressure (IOP)8,9,10,11,12,13,143,15,16,17,18. Left untreated, chronically elevated IOP leads to progressive and irreversible damage to the retina and optic nerve head causing radial blindness1,2,19. All current methods for slowing the progression of glaucoma focus on reducing IOP, either by decreasing the rate of production of AH by the ciliary body or enhancing it's outflow1,8,9,10,11,12,13,14. The trabecular meshwork (TM) plays a vital role in actively regulating the primary AH outflow pathway and its improper function is a causative factor for hypertensive glaucoma1,2,19. However, the molecular mechanisms associated with TM dysfunction and how it regulates AH drainage are not yet fully understood and is currently a major focus of glaucoma research1,2,19,20. While several genome-wide association studies (GWAS) have linked a number of genes to glaucoma and increased resistance to AH outflow facility at the TM, the exact molecular mechanisms that lead to disease are not yet fully understood21,22,23,24,25.
Animal models have greatly enhanced our current knowledge of disease progression in glaucoma (extensively reviewed in3,15,16,26,27,28,29,30,31,32,33). Several pioneering methods have been developed to study the TM34,35,36 and these methods have been widely used to advance our current understanding of normal and diseased tissue. One area that has not been extensively explored is the use of genetically modified mouse models to study the molecular mechanisms of TM failure. Transgenic knock-in and knock-out mouse studies of TM associated genes, such as Myocilin (Myoc)37,38 and Cyp1b139, have been the primary tools for studying the molecular mechanisms of TM function. Understandably, the small size of the TM in mice represents a serious hurdle that must be overcome in order to begin to study this tissue. Mouse models represent a powerful tool for studying the genetics and molecular mechanisms of disease, while advances in LCM technologies provide the necessary tools to empower the study of the smallest and most delicate tissues, including the TM.
In this report, a robust and reproducible method is described for the LCM of highly enriched TM from mouse eyes along with subsequent RNA isolation, and amplification for downstream expression analysis. Similar methods have been used successfully in mice to isolate other types of eye tissues40,41,42,43,44, the methodology reported herein can be applied to other discrete tissues of the eye to study RNA, microRNA, DNA, and proteins. Importantly, this technique enables the use of genetically modified mice to better understand the molecular pathogenesis of TM impairment in glaucoma and ocular disease3,15,16,17,18,26,31,45,46. The ability to isolate the TM of mouse eyes by LCM will be a useful technique in obtaining further insights into the molecular mechanisms of several ocular diseases.